Vinorelbine for Recurrent ACLC
Clinical trial NCT03397953 · COMPLETED
Trial details
- NCT number
- NCT03397953
- Sponsor
- Children's Cancer Group, China
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2022-07-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.